Benjamin Graham fit · Defensive deep-value investing
Is Neurocrine Biosciences, Inc. (NBIX) a Benjamin Graham Stock?
Meets 4/7 Graham criteria - classic deep-value candidate.
78/100
BLikely Graham stock
4/7 criteria passed
+10 sector-quality lift. Top-quintile within its sector on 5 of 5 quality metrics. Raw pillar score 68 → lifted to 78 before grade derivation.
Benjamin Graham's Criteria, Applied to NBIX
P/E ≤ 15
key22.6x
P/B ≤ 1.5
key4.4x
Current ratio ≥ 2
2.9x
Debt / Equity ≤ 1
0.1x
How NBIX Scores on Other Strategies
Live Financial Snapshot
Market cap
$15.88B
P/E (TTM)
22.6x
ROIC (TTM)
13.68%
Gross margin
98.17%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is NBIX's Benjamin Graham fit score?
NBIX scores 78/100 on our Benjamin Graham fit engine - grade B. Meets 4/7 Graham criteria - classic deep-value candidate.
Does Benjamin Graham actually own NBIX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends NBIX.
How often is this score updated?
NBIX's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends NBIX.